Qu Biologics is recruiting for a Phase 1/2 clinical research trial - TopicsExpress



          

Qu Biologics is recruiting for a Phase 1/2 clinical research trial for people living with moderate to severe Crohn’s disease. Qu Biologics is developing a new immunotherapeutic treatment. Site Specific Immunomodulators (SSIs) are being designed with the goal of stimulating the body’s immune system to reverse the chronic inflammation underlying many conditions such as Crohn’s disease. To learn more about the trial and complete an online pre-screening questionnaire to assess your eligibility, visit qucrohnstrial The clinical research trial takes place in Vancouver, BC. For more information, call 1.855.209.9680 or email qucrohnstrial.aa@gmail.
Posted on: Fri, 17 Oct 2014 23:20:27 +0000

Trending Topics



Recently Viewed Topics




© 2015